Polaris Venture Management Co. V, L.L.C is an investment fund managing more than $62.4 million ran by Lauren Crockett. There are currently 7 companies in Mrs. Crockett’s portfolio. The largest investments include Fate Therapeutics Inc and Lyra Therapeutics, together worth $58.3 million.
As of 5th August 2021, Polaris Venture Management Co. V, L.L.C’s top holding is 569,889 shares of Fate Therapeutics Inc currently worth over $49.5 million and making up 79.2% of the portfolio value.
Relative to the number of outstanding shares of Fate Therapeutics Inc, Polaris Venture Management Co. V, L.L.C owns more than approximately 0.1% of the company.
In addition, the fund holds 1,100,852 shares of Lyra Therapeutics worth $8.84 million, whose value fell 48.4% in the past six months.
The third-largest holding is X4 Pharmaceuticals worth $2.03 million and the next is Atyr Pharma Inc worth $637 thousand, with 130,572 shares owned.
Currently, Polaris Venture Management Co. V, L.L.C's portfolio is worth at least $62.4 million. The total portfolio value may be much higher due to cash
assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.
The Polaris Venture Management Co. V, L.L.C office and employees reside in Boston, Massachusetts. According to the last 13-F report filed with the SEC, Lauren Crockett serves as the Authorized Signatory at Polaris Venture Management Co. V, L.L.C.
There are companies that Polaris Venture Management Co. V, L.L.C is getting rid of from its portfolio.
Polaris Venture Management Co. V, L.L.C closed its position in Selecta Biosciences Inc on 12th August 2021.
It sold the previously owned 2,773,479 shares for $12.6 million.
Lauren Crockett also disclosed a decreased stake in Dare Bioscience Inc by approximately 0.1%.
This leaves the value of the investment at $617 thousand and 326,240 shares.
The two most similar investment funds to Polaris Venture Management Co. V, L.L.C are Polaris Venture Management Co Iv and Dw Partners, L.P.. They manage $62.4 million and $62.3 million respectively.
Polaris Venture Management Co. V, L.L.C’s portfolio is diversified across 1 sector.
Currently, their heaviest sector is Health Care — making up 100.0% of
the total portfolio value.
The fund focuses on investments in the United States as
100.0% of the portfolio companies
are based in the United States.
The majority of the companies in the fund’s portfolio are small-cap stocks.
Stocks with a size of more than $100 million in market cap make up
57% of the total holdings value.
On the other hand, large-cap stocks make up only approximately 0.1% of the portfolio.
The average market cap of the portfolio companies is close to $1.27 billion.
These positions were updated on August 12th based on the fund’s latest 13F filing. Quickly find out what the most recently closed or increased positions are.
| Security | Shares Owned | Value | Allocation |
|---|---|---|---|
| Fate Therapeutics Inc |
No change
569,889
|
$49,461,000 | 79.24% |
| Selecta Biosciences Inc |
Closed
2,773,479
|
$12,550,000 | |
| Lyra Therapeutics, Inc. |
No change
1,100,852
|
$8,840,000 | 14.16% |
| X4 Pharmaceuticals, Inc. |
No change
311,492
|
$2,025,000 | 3.24% |
| Atyr Pharma Inc |
No change
130,572
|
$637,000 | 1.02% |
| Dare Bioscience Inc |
0.00%
326,240
|
$617,000 | 0.99% |
| Genocea Biosciences Inc |
No change
197,345
|
$462,000 | 0.74% |
| Pulmatrix Inc |
No change
359,441
|
$374,000 | 0.60% |
| No transactions found | |||
| Showing first 500 out of 8 holdings | |||